Most cancers is likely one of the main causes of loss of life on this planet, with near 10 million individuals dying annually. Discovering progressive therapeutic methods to deal with this subject is critical, as they’ll overcome the constraints of typical therapies [1]. Whereas conventional most cancers therapies akin to chemotherapy, radiotherapy, and surgical procedure have made an enormous distinction in affected person outcomes, these kind of therapies usually undergo from poor selectivity, systemic toxicity, restricted efficacy in opposition to metastatic illness, and the event of resistance mechanisms [2], [3], [4]. Lately, most cancers immunotherapy has turn into one of many revolutionary approaches that makes use of the facility of the affected person’s immune system to determine and get rid of malignant cells [5]. Nonetheless, a big share of sufferers present low or non permanent responses, owing to mechanisms of immune escape and the extremely immunosuppressive tumor microenvironment (TME) [6], [7].
Immunogenic cell loss of life (ICD) is the method of turning dying tumor cells from inert particles into instructive vaccines by linking antigenicity and adjuvanticity via the emission of hazard alerts (DAMPs), which license adaptive immunity [8], [9]. Canonical hallmarks of ICD are pre-apoptotic publicity of calreticulin (CRT) on the plasma membrane, lively secretion of ATP, and late launch of HMGB1, which collectively recruit and mature dendritic cells (DCs) for cross-priming of cytotoxic T lymphocytes [10], [11], [12]. Though a number of cytotoxic modalities (together with radiotherapy) can induce ICD, their effectiveness is proscribed by tumor-intrinsic stress adaptation and a suppressive microenvironment that modulates DAMP bioavailability [13]. Nanomedicine supplies a pathway to manage the supply of stress at a particular web site and time inside tumor cells. It could additionally modulate the destiny of DAMPs within the pericellular setting. Due to this fact, ICD will be elicited in a spatially confined and fewer poisonous method [14], [15]. Latest polymer-delivery frameworks emphasize that degradable artificial backbones (e.g., polyesters, polycarbonates, polyanhydrides, polypeptides, and polyethers) present tunable chemistry, cargo compatibility, and immune-interfacing properties that may be exploited to co-package ICD inducers with immunomodulators in a single provider [16]. This overview focuses on nanomedicine-enabled methods that purposely engineer ER stress, amplify DAMP signaling, and translate the ensuing innate cues into sturdy antitumor activation.
On the mechanistic core of ICD is ER stress and the unfolded protein response (UPR), which integrates perturbations in proteostasis into immunostimulatory outputs [17], [18]. Endoplasmic reticulum stress refers to a state wherein ER proteostasis demand exceeds folding and quality-control capability, resulting in the buildup of non-native proteins and broader dysfunction in ER duties akin to disulfide bond formation, calcium dealing with, and lipid homeostasis. In tumors, ER stress is regularly provoked by microenvironmental constraints akin to hypoxia and nutrient deprivation, in addition to by oncogene-driven will increase in protein synthesis and secretory load, and it may be additional intensified by cytotoxic therapies that disrupt redox steadiness or proteasome operate [18], [19]. To revive homeostasis, cells have interaction the unfolded protein response, a three-arm signaling community initiated by the ER transmembrane sensors PERK, IRE1α, and ATF6, that are restrained beneath basal circumstances by the chaperone BiP/GRP78. Upon stress, sensor activation coordinates an adaptive program. It reduces incoming protein load via translational attenuation (PERK-mediated eIF2α phosphorylation with selective ATF4 translation). It expands folding capability through chaperone induction. It accelerates disposal of terminally misfolded proteins via ER-associated degradation. In some contexts, it additionally makes use of regulated IRE1-dependent mRNA decay. ATF6 provides a complementary transcriptional module after Golgi trafficking and proteolytic activation [20], [21].
This adapt-or-die logic is very vital in most cancers. Power, sublethal UPR signaling can assist tumor survival, plasticity, and remedy resistance. Nonetheless, when ER stress is intense or extended, the UPR can swap from restoration to dedication to cell loss of life. This swap entails built-in pro-death outputs, together with ATF4–CHOP-linked transcriptional reworking and stress-kinase signaling downstream of IRE1α [19], [20]. Per this threshold conduct, disabling key adaptive nodes can unmask immunogenic tumor-cell demise: genetic ablation or pharmacologic inhibition of PERK in melanoma fashions compromised ER-stress tolerance and promoted a vacuolating, caspase-independent loss of life program (paraptosis) that enhanced sort I interferon-associated antigen-presenting cell reworking and protecting T-cell responses, highlighting PERK as a context-dependent survival issue and an immunomodulatory vulnerability [22]. The branch-specific hyperlinks between UPR signaling and ICD hallmarks are detailed later, so right here we emphasize a sensible framing used all through this overview: ER stress magnitude, length, and subcellular localization decide whether or not the UPR primarily buffers tumors in opposition to damage or as an alternative drives immunogenic stress and tumor-cell elimination [18], [20].
Amongst UPR branches, PERK-dependent phosphorylation of eIF2α is a typical biomarker and mechanistic determinant of the execution of ICD that licenses the translocation of CRT to the cell floor previous to overt apoptosis [17], [23]. In parallel, autophagy-dependent vesicular transport and pannexin 1 hemichannels are routes of launch of ATP as a find-me chemotactic cue and inflammasome set off in myeloid cells [24]. As membranes turn into disrupted, HMGB1 is launched from the nucleus to bind to TLR4 on DCs to speed up antigen processing and cross-presentation [25]. These temporally ordered DAMPs (CRT publicity, ATP secretion, HMGB1 launch) type a coherent code, via which ER proximal stress is decoded into orchestrated innate and adaptive immune responses [17], [23], [24], [25].
Floor-exposed CRT acts as an eat-me sign by ligating scavenger receptor LRP1/CD91 on phagocytes to boost internalization of harassed cells or dying tumor cells in favor of immunogenic processing over tolerogenic clearance [26]. DAMP sensing then gates DC trafficking: HMGB1–TLR4 and ATP–P2X7 signaling drive tumor-infiltrating DC emigration to draining lymph nodes, which is a prerequisite for efficient cross-priming [27]. As well as, therapy-induced cytosolic DNA can set off the cGAS-STING axis that prompts sort I interferon (IFN-I), resulting in elevated cross-presentation and T cell recruitment [28]. Foundational work demonstrated that publicity to CRT shouldn’t be merely correlative however causal for the immunogenicity of cell loss of life, establishing the connection between the outputs of ER stress and antitumor immunity [29]. Collectively, these pathways represent the mechanism by which correctly choreographed loss of life converts tumor antigens into vaccines in situ [26], [27], [28], [29].
Nanotechnology is especially well-suited to inflict this choreography inside tumors. Notably, biomaterials will be lively ICD inducers somewhat than passive carriers, utilizing material-derived cues (stress responses or organelle perturbation) to drive DAMP publicity and create native ‘in situ vaccination’ niches [30]. Photodynamic nanoplatforms improve localized reactive oxygen species (ROS) manufacturing to disrupt ER homeostasis and increase the efficacy of ICD, and package deal photosensitizing brokers and oxygen modulating brokers to beat hypoxia that blunts the emission of DAMPs [14], [31]. Rational nanoplatform design additionally permits spatiotemporal management (e.g., light-triggered launch or subcellular ER concentrating on) to coordinate publicity of CRT with ATP/HMGB1 availability for optimum DC activation [31], [32]. Past phototherapy, rising nano-ICD ideas contain using hybrid supplies and responsive carriers to co-deliver ICD inducers with immune-active cargos, forming self-adjuvanting formulations which hyperlink tumor cell stress with checkpoint-enabled T cell responses [33]. Programmable mRNA nanomedicines are starting to encode ICD straight: the TITUR platform enabled tumor-selective expression of an ICD-inducing protein and mixed with PD-1 blockade, transformed immunologically chilly tumors [34]. Collectively, these advances assist redefine ICD from a serendipitous byproduct of cytotoxic remedy right into a programmable therapeutic endpoint achievable via supplies engineering [14], [31], [32], [33].
As proven in Fig. 1(a), tendencies in OpenAlex publications present a particular and sustained improve within the variety of publications, and in Fig. 1(b), we will see key milestones indicating a maturing data base and rising translational momentum. Collectively, these observations inspire us to give attention to an integrative overview of mechanisms, applied sciences, and alternatives on this area (Fig. 1). We synthesize methods to make use of nanomedicine to (i) induce ER stress alongside outlined UPR axes, (ii) tune the magnitude, timing, and localization of ICD outputs, and (iii) translate these alerts into efficient dendritic cell activation and T-cell priming whereas limiting immunosuppressive sink pathway activation. Past DAMP emission, we spotlight rising approaches to extend antigenicity, together with coordinating antigen publicity with cross-presentation and immune priming, and we tackle the problem of DAMP integrity as a design constraint formed by extracellular destiny processes within the tumor microenvironment. We spotlight ER subcellular concentrating on, the place supply and retention guidelines enable eIF2α-linked calreticulin publicity to be maximized with minimal cytotoxic spillover. We additionally tackle the newest progress in nano-enabled photo- and chemo-immunotherapies that pair ICD programming with checkpoint blockade to transform chilly tumors into scorching lesions, and we introduce immunogenic ER stress with out overt cell loss of life as a tunable window for vaccination-like priming. Lastly, we talk about translational benchmarks for facilitating cross-study comparability and scientific translation.
